Article
Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA.
Cancer science - 1 Sept 2021
Sunami Kuniko, Bando Hideaki, Yatabe Yasushi, Naito Yoichi, Takahashi Hideaki, Tsuchihara Katsuya, Toyooka Shinichi, Mimori Koshi, Kohsaka Shinji, Uetake Hiroyuki, Kinoshita Ichiro, Komine Keigo, Takeda Masayuki, Hayashida Tetsu, Tamura Kenji, Nishio Kazuto, Yamamoto Noboru
Abstract excerpt
Comprehensive genomic profiling (CGP) is being increasingly used for the routine clinical management of solid cancers. In July 2018, the use of tumor tissue-based CGP assays became available for all solid cancers under the universal health insurance system in Japan. Several restrictions presently exist, such as patient eligibility and limitations on the opportunities to perform such assays. The clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.